Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Freedman RA, Gelman RS, Wefel JS, Melisko ME, Hess KR, Connolly RM, Van Poznak CH, Niravath PA, Puhalla SL, Ibrahim N, Blackwell KL, Moy B, Herold C, Liu MC, Lowe A, Agar NY, Ryabin N, Farooq S, Lawler E, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU.

J Clin Oncol. 2016 Mar 20;34(9):945-52. doi: 10.1200/JCO.2015.63.0343. Epub 2016 Feb 1.

2.

Breast cancer brain metastases: the last frontier.

Leone JP, Leone BA.

Exp Hematol Oncol. 2015 Nov 24;4:33. doi: 10.1186/s40164-015-0028-8. eCollection 2015. Review.

3.

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.

Subbiah IM, Lei X, Weinberg JS, Sulman EP, Chavez-MacGregor M, Tripathy D, Gupta R, Varma A, Chouhan J, Guevarra RP, Valero V, Gilbert MR, Gonzalez-Angulo AM.

J Clin Oncol. 2015 Jul 10;33(20):2239-45. doi: 10.1200/JCO.2014.58.8517. Epub 2015 May 18.

4.

In-line phase-contrast and grating-based phase-contrast synchrotron imaging study of brain micrometastasis of breast cancer.

Huang S, Kou B, Chi Y, Xi Y, Cao Y, Cui W, Hu X, Shao Z, Guo H, Fu Y, Xiao T, Sun J, Zhao J, Wang Y, Wu J.

Sci Rep. 2015 Mar 30;5:9418. doi: 10.1038/srep09418.

5.

Current approaches to the treatment of metastatic brain tumours.

Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ.

Nat Rev Clin Oncol. 2014 Apr;11(4):203-22. doi: 10.1038/nrclinonc.2014.25. Epub 2014 Feb 25. Review.

6.

Phase II trial of patupilone in patients with brain metastases from breast cancer.

Peereboom DM, Murphy C, Ahluwalia MS, Conlin A, Eichler A, Van Poznak C, Baar J, Elson P, Seidman AD.

Neuro Oncol. 2014 Apr;16(4):579-83. doi: 10.1093/neuonc/not305. Epub 2014 Jan 26.

7.

Breast cancer brain metastases: new directions in systemic therapy.

Lin NU.

Ecancermedicalscience. 2013 Apr 18;7:307. doi: 10.3332/ecancer.2013.307. Print 2013.

8.

Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model.

Zhou H, Chen M, Zhao D.

PLoS One. 2013 Apr 29;8(4):e62238. doi: 10.1371/journal.pone.0062238. Print 2013.

9.

Innovative therapeutic strategies in the treatment of brain metastases.

Caffo M, Barresi V, Caruso G, Cutugno M, La Fata G, Venza M, Alafaci C, Tomasello F.

Int J Mol Sci. 2013 Jan 22;14(1):2135-74. doi: 10.3390/ijms14012135.

10.

Complete radiologic response and long-term survival with use of systemic high-dose methotrexate for breast cancer-associated leptomeningeal disease.

Santa-Maria CA, Cimino-Mathews A, Moseley KF, Wolff AC, Blakeley JO, Connolly RM.

Clin Breast Cancer. 2012 Dec;12(6):445-9. doi: 10.1016/j.clbc.2012.07.010. Epub 2012 Sep 24. No abstract available.

11.

Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.

Park EJ, Zhang YZ, Vykhodtseva N, McDannold N.

J Control Release. 2012 Nov 10;163(3):277-84. doi: 10.1016/j.jconrel.2012.09.007. Epub 2012 Sep 18.

12.

Treatment of Breast Cancer Brain Metastases.

Freedman RA, Anders CK.

Curr Breast Cancer Rep. 2012 Mar 1;4(1):1-9. Epub 2011 Dec 21.

13.

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.

Freedman RA, Bullitt E, Sun L, Gelman R, Harris G, Ligibel JA, Krop IE, Partridge AH, Eisenberg E, Winer EP, Lin NU.

Clin Breast Cancer. 2011 Dec;11(6):376-83. doi: 10.1016/j.clbc.2011.03.024. Epub 2011 Jun 22.

14.

Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.

Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2111-7. doi: 10.1016/j.ijrobp.2011.02.027. Epub 2011 Apr 15.

15.

The biology of brain metastases-translation to new therapies.

Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK.

Nat Rev Clin Oncol. 2011 Jun;8(6):344-56. doi: 10.1038/nrclinonc.2011.58. Epub 2011 Apr 12. Review.

16.

Prognostic scores in brain metastases from breast cancer.

Nieder C, Marienhagen K, Astner ST, Molls M.

BMC Cancer. 2009 Apr 7;9:105. doi: 10.1186/1471-2407-9-105.

17.

Prognostic indices for brain metastases--usefulness and challenges.

Nieder C, Mehta MP.

Radiat Oncol. 2009 Mar 4;4:10. doi: 10.1186/1748-717X-4-10. Review.

18.

Have changes in systemic treatment improved survival in patients with breast cancer metastatic to the brain?

Nieder C, Marienhagen K, Dalhaug A, Norum J.

J Oncol. 2008;2008:417137. doi: 10.1155/2008/417137. Epub 2008 Sep 23.

Supplemental Content

Support Center